Feneprofen calcium salt dihydrate en es it fr

Feneprofen calcium salt dihydrate Brand names, Feneprofen calcium salt dihydrate Analogs

Feneprofen calcium salt dihydrate Brand Names Mixture

  • No information avaliable

Feneprofen calcium salt dihydrate Chemical_Formula

C24H33N3O4

Feneprofen calcium salt dihydrate RX_link

No information avaliable

Feneprofen calcium salt dihydrate fda sheet

Feneprofen_calcium_salt_dihydrate FDA

Feneprofen calcium salt dihydrate msds (material safety sheet)

Feneprofen calcium salt dihydrate Synthesis Reference

No information avaliable

Feneprofen calcium salt dihydrate Molecular Weight

427.537 g/mol

Feneprofen calcium salt dihydrate Melting Point

No information avaliable

Feneprofen calcium salt dihydrate H2O Solubility

Very slightly soluble

Feneprofen calcium salt dihydrate State

Solid

Feneprofen calcium salt dihydrate LogP

1.876

Feneprofen calcium salt dihydrate Dosage Forms

Tablets (extended release - 500 mg)

Feneprofen calcium salt dihydrate Indication

For the treatment of chronic angina. It should be used in combination with amlodipine, beta-blockers or nitrates.

Feneprofen calcium salt dihydrate Pharmacology

Ranolazine has antianginal and anti-ischemic effects that do not depend upon reductions in heart rate or blood pressure. It is the first new anti-anginal developed in over 20 years.

Feneprofen calcium salt dihydrate Absorption

Absorption is highly variable. After oral administration of ranolazine as a solution, 73% of the dose is systemically available as ranolazine or metabolites. The bioavailability of oral ranolazine relative to that from a solution is 76%.

Feneprofen calcium salt dihydrate side effects and Toxicity

In the event of overdose, the expected symptoms would be dizziness, nausea/vomiting, diplopia, paresthesia, and confusion. Syncope with prolonged loss of consciousness may develop.

Feneprofen calcium salt dihydrate Patient Information

AMITIZA™ may cause nausea. If this occurs, concomitant administration of food with AMITIZA™ may reduce symptoms of nausea. AMITIZA™ should not be administered to patients that have severe diarrhea. Patients should be aware of the possible occurrence of diarrhea during treatment. If the diarrhea becomes severe consult your physician.

Feneprofen calcium salt dihydrate Organisms Affected

Humans and other mammals